Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Named Roche NimbleGen Service Provider

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics has become a certified service provider for the Roche NimbleGen SeqCap EZ Exome workflow, the firms announced today.

Aliso Viejo, Calif.-based Ambry will provide target enrichment services using SeqCap EZ Human Exome combined with next-generation sequencing services.

The SeqCap EZ Exome technology uses a single tube of stable DNA oligos to capture all exons in solution in a simple, scalable workflow, and contains 2.1 million empirically optimized DNA probes, according to Roche NimbleGen.

Under the partnership, Ambry will process customers' genomic DNA samples for enrichment using SeqCap to capture all human coding exons, and sequence the enriched samples using short-read, paired-end sequencing. According to the firms, Ambry is Roche NimbleGen's first service provider in the US offering the SeqCap EZ Human Exome product.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.